Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Uncover various ways to access cash for debt repayment that can streamline your path to financial stability. Explore your options today.
22,799 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
A cultural meme is shaping money decisions in licensing, estate planning, and brand strategy. Here’s how chuck norris...
Oil’s surge fuels a wave of gains in key energy ETFs, led by XLE, OIH, and PBT, as supply, demand, and drilling budge...
When Gartner stock sagged today, traders weighed a price-target cut and the broader tech sentiment. This article brea...
When market turbulence rises, even growth-focused firms recalibrate. Francis Financial doubles down on fixed income, ...
Metaplanet, the nation’s largest corporate bitcoin holder outside the United States, posted a hefty quarterly loss ti...
JPMorgan boosted Hewlett Packard Enterprise's price target to $37, citing easing memory costs and improving earnings ...
The Virtus InfraCap U.S. Preferred Stock ETF (PFFA) offers a 9.5% yield, backed by 188 holdings and modest leverage. ...
A midweek rally lifted U.S. stocks as investors weighed geopolitical headlines and a high-profile IPO. The Nasdaq led...
QUBT surged alongside quantum peers on policy chatter, but the rally raises questions about fundamentals and governme...
Stocks climbed as heavyweight tech names posted solid results and ceasefire hopes supported risk appetite, sending th...
A trillion-dollar AI capex push by hyperscalers and chipmakers is fueling a fierce debate over whether the spending w...